Status:
COMPLETED
Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin
Lead Sponsor:
Peregrine Eye and Laser Institute
Conditions:
Cataract Senile
Endophthalmitis
Eligibility:
All Genders
21-100 years
Phase:
PHASE4
Brief Summary
Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis
Detailed Description
Randomized clinical trial comparing corneal and retinal changes after intracameral levofloxacin or moxifloxacin administered at the end of surgery among eyes undergoing uncomplicated phacoemulsificati...
Eligibility Criteria
Inclusion
- Eyes undergoing uncomplicated cataract surgery by phacoemulsification
Exclusion
- Corneal opacities, corneal dystrophies, glaucoma, uveitis, retinopathy, optic neuropathy, concomitant infection (blepharitis, hordeolum, or conjunctivitis) or uncontrolled systemic disease and intraoperative complications that may affect visual outcomes were excluded from the study
Key Trial Info
Start Date :
January 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2018
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04403334
Start Date
January 2 2018
End Date
April 28 2018
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peregrine Eye and Laser Instittute
Makati City, MM, Philippines, 1209